PortfoliosLab logoPortfoliosLab logo
INO vs. MDU
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

INO vs. MDU - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Inovio Pharmaceuticals, Inc. (INO) and MDU Resources Group, Inc. (MDU). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, INO achieves a -30.46% return, which is significantly lower than MDU's 7.43% return. Over the past 10 years, INO has underperformed MDU with an annualized return of -37.50%, while MDU has yielded a comparatively higher 12.29% annualized return.


INO

1D
-5.47%
1M
10.00%
YTD
-30.46%
6M
-36.98%
1Y
-42.38%
3Y*
-44.15%
5Y*
-58.19%
10Y*
-37.50%

MDU

1D
0.53%
1M
-7.83%
YTD
7.43%
6M
2.77%
1Y
25.39%
3Y*
26.05%
5Y*
13.22%
10Y*
12.29%
*Multi-year figures are annualized to reflect compound growth (CAGR)

INO vs. MDU - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
INO
Inovio Pharmaceuticals, Inc.
-30.46%-4.92%-70.10%-67.31%-68.74%-43.62%168.18%-17.50%-3.15%-40.49%
MDU
MDU Resources Group, Inc.
7.43%11.77%68.01%-1.94%1.46%20.37%-8.31%28.44%-8.64%-3.87%

Correlation

The correlation between INO and MDU is -0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.02

Correlation (3Y)
Calculated over the trailing 3-year period

0.15

Correlation (5Y)
Calculated over the trailing 5-year period

0.17

Correlation (10Y)
Calculated over the trailing 10-year period

0.12

Correlation (All Time)
Calculated using the full available price history since Dec 9, 1998

0.11

The correlation between INO and MDU shifts across timeframes, from -0.02 (1 year) to 0.17 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

INO:

$836.13M

MDU:

$4.31B

EPS

INO:

-$63.15

MDU:

$0.92

PB Ratio

INO:

0.14

MDU:

1.48

Total Revenue (TTM)

INO:

$0.00

MDU:

$1.81B

Gross Profit (TTM)

INO:

-$1.50M

MDU:

$848.35M

EBITDA (TTM)

INO:

-$22.01B

MDU:

$528.72M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

INO vs. MDU — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

INO
INO Risk / Return Rank: 2121
Overall Rank
INO Sharpe Ratio Rank: 2020
Sharpe Ratio Rank
INO Sortino Ratio Rank: 2626
Sortino Ratio Rank
INO Omega Ratio Rank: 2525
Omega Ratio Rank
INO Calmar Ratio Rank: 1717
Calmar Ratio Rank
INO Martin Ratio Rank: 1818
Martin Ratio Rank

MDU
MDU Risk / Return Rank: 7373
Overall Rank
MDU Sharpe Ratio Rank: 7575
Sharpe Ratio Rank
MDU Sortino Ratio Rank: 6767
Sortino Ratio Rank
MDU Omega Ratio Rank: 6868
Omega Ratio Rank
MDU Calmar Ratio Rank: 7979
Calmar Ratio Rank
MDU Martin Ratio Rank: 7777
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

INO vs. MDU - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Inovio Pharmaceuticals, Inc. (INO) and MDU Resources Group, Inc. (MDU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


INOMDUDifference

Sharpe ratio

Return per unit of total volatility

-0.48

1.18

-1.66

Sortino ratio

Return per unit of downside risk

-0.17

1.64

-1.81

Omega ratio

Gain probability vs. loss probability

0.97

1.22

-0.24

Calmar ratio

Return relative to maximum drawdown

-0.62

2.56

-3.19

Martin ratio

Return relative to average drawdown

-1.07

5.61

-6.69

INO vs. MDU - Sharpe Ratio Comparison

The current INO Sharpe Ratio is -0.48, which is lower than the MDU Sharpe Ratio of 1.18. The chart below compares the historical Sharpe Ratios of INO and MDU, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


INOMDUDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.48

1.18

-1.66

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.68

0.58

-1.25

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.40

0.45

-0.86

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.18

0.45

-0.63

Drawdowns

INO vs. MDU - Drawdown Comparison

The maximum INO drawdown since its inception was -99.95%, which is greater than MDU's maximum drawdown of -62.17%. Use the drawdown chart below to compare losses from any high point for INO and MDU.


Loading charts...

Drawdown Indicators


INOMDUDifference

Max Drawdown

Largest peak-to-trough decline

-99.95%

-62.17%

-37.78%

Max Drawdown (1Y)

Largest decline over 1 year

-63.41%

-9.70%

-53.71%

Max Drawdown (3Y)

Largest decline over 3 years

-92.44%

-21.48%

-70.96%

Max Drawdown (5Y)

Largest decline over 5 years

-99.13%

-23.58%

-75.55%

Max Drawdown (10Y)

Largest decline over 10 years

-99.72%

-51.41%

-48.31%

Current Drawdown

Current decline from peak

-99.95%

-8.64%

-91.31%

Average Drawdown

Average peak-to-trough decline

-92.35%

-14.33%

-78.02%

Ulcer Index

Depth and duration of drawdowns from previous peaks

36.86%

4.43%

+32.43%

Volatility

INO vs. MDU - Volatility Comparison

Inovio Pharmaceuticals, Inc. (INO) has a higher volatility of 22.43% compared to MDU Resources Group, Inc. (MDU) at 5.17%. This indicates that INO's price experiences larger fluctuations and is considered to be riskier than MDU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


INOMDUDifference

Volatility (1M)

Calculated over the trailing 1-month period

22.43%

5.17%

+17.26%

Volatility (6M)

Calculated over the trailing 6-month period

66.21%

14.96%

+51.25%

Volatility (1Y)

Calculated over the trailing 1-year period

88.22%

21.61%

+66.61%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

86.04%

23.06%

+62.98%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

93.38%

27.12%

+66.26%

Dividends

INO vs. MDU - Dividend Comparison

INO has not paid dividends to shareholders, while MDU's dividend yield for the trailing twelve months is around 2.64%.


PositionTTM20252024202320222021202020192018201720162015
INO
Inovio Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
MDU
MDU Resources Group, Inc.
2.64%2.77%1.89%3.16%2.88%2.77%3.17%2.74%3.33%2.88%2.62%4.01%

Financials

INO vs. MDU - Financials Comparison

This section allows you to compare key financial metrics between Inovio Pharmaceuticals, Inc. and MDU Resources Group, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B2.00B202220232024202520260
606.00M
(INO) Total Revenue
(MDU) Total Revenue
Values in USD except per share items

Frequently Asked Questions


INO and MDU have a correlation of -0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

INO has higher volatility (22.43%) compared to MDU (5.17%). In terms of maximum drawdown, INO dropped -99.95% vs MDU's -62.17%.

MDU currently has the higher Sharpe Ratio (1.18 vs -0.48), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for INO and MDU

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer